Billion-dollar takeover bid for Healius scrapped
Australian Clinical Labs withdrew its $1.6 billion offer.
Australian Clinical Labs has abandoned its $1.6 billion takeover bid for Healius following a fall in Healius’ share price and opposition from the consumer watchdog.
If Australian Clinical Labs (ACL) had merged with Healius, it would have created a pathology super-group with almost 3000 collection centres, conducting tens of millions of pathology tests a year.
